Skip to content

Mary Cannon

6 papers in the library · 1,006 citations · publishing 2004-2026

Papers

Sort Most recent Most cited

Using AI to Detect Psychosis Relapse: Scoping Review.

JMIR Mental Health June 16, 2026 Lorenzo Ghelfi, Jack Healy, Francesco Piacenza et al.

Abstract Background Psychotic disorder represents a leading cause of disability worldwide, and relapse in psychosis is common. Artificial intelligence (AI) is increasingly recognized as a method that could aid clinical monitoring for individuals experiencing psychosis. Objective This review aims to map the existing literature on AI-based approaches—including machine learning, deep learning, and...

Incidence and Persistence of Psychotic Experiences in the General Population: Systematic Review and Meta-Analysis.

Schizophrenia Bulletin July 1, 2023 Lorna Staines, Colm Healy, Felim Murphy et al.

Background and hypothesis: Psychotic experiences (PEs) are associated with increased risk for mental disorders, in particular persistent PEs. PEs therefore might be useful within intervention research. We sought to systematically determine the incidence and persistence of PEs in the general population. Study design: A double-blind search of databases (Embase, Pubmed PMC, Psychinfo, Medline, and...

DOI: 10.1093/schbul/sbad056 (opens in new tab) Full text (opens in new tab) Humans Incidence Risk factors Mental disorders +2

Perceptual abnormalities in an ultra-high risk for psychosis population relationship to trauma and co-morbid disorder.

Early Intervention in Psychiatry April 2019 Karen O' Connor, Barnaby Nelson, Mary Cannon et al.

The aims of this study were 3-fold. We wished to investigate whether at baseline entry to an ultra-high risk (UHR) clinic whether: (1) perceptual abnormalities are more prevalent in those young people with co-morbid psychiatric diagnoses, (2) perceptual abnormalities are more prevalent in those young people with histories of childhood adversity (childhood trauma, bullying) and (3) perceptual...

DOI: 10.1111/eip.12469 (opens in new tab) Full text (opens in new tab) Hallucinations Psychosis Trauma Ultra high risk

Chronic adolescent exposure to Δ-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes.

Neuropsychopharmacology October 2010 Colm M P O'Tuathaigh, Magdalena Hryniewiecka, Aine Behan et al.

Cannabis use confers a two-fold increase in the risk for psychosis, with adolescent use conferring even greater risk. A high-low activity catechol-O-methyltransferase (COMT) polymorphism may modulate the effects of adolescent Δ-9-tetrahydrocannabinol (THC) exposure on the risk for adult psychosis. Mice with knockout of the COMT gene were treated chronically with THC (4.0 and 8.0 mg/kg over 20...

Psychotic symptoms in the general population – an evolutionary perspective

The British Journal of Psychiatry August 31, 2010 Ian Kelleher, Jack A. Jenner, Mary Cannon 82 citations

Our ideas about the intrinsically pathological nature of hallucinations and delusions are being challenged by findings from epidemiology, neuroimaging and clinical research. Population-based studies using both self-report and interview surveys show that the prevalence of psychotic symptoms is far greater than had been previously considered, prompting us to re-evaluate these psychotic symptoms...

Causal association between cannabis and psychosis: examination of the evidence

The British Journal of Psychiatry January 30, 2004 Louise Arseneault, Mary Cannon, John Witton et al. 924 citations

BACKGROUND: Controversy remains as to whether cannabis acts as a causal risk factor for schizophrenia or other functional psychotic illnesses. AIMS: To examine critically the evidence that cannabis causes psychosis using established criteria of causality. METHOD: We identified five studies that included a well-defined sample drawn from population-based registers or cohorts and used prospective...